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OBJECTIVE — Moderate alcohol consumption is associated with reduced incidence of type
2 diabetes and cardiovascular mortality and increases adiponectin concentrations, but effects
might differ according to sex and beverage consumed.
RESEARCH DESIGN AND METHODS — A total of 72 healthy individuals (22–56
years) were enrolled in this randomized controlled crossover trial. After washout, two interven-
tions for 3 weeks followed: ethanol (concentration 12.5%), beer (5.6%), or red wine (12.5%)
equivalent to 30 g ethanol/day for men and 20 g/day for women or the same de-alcoholized
beverages or water. Adiponectin was measured by sandwich enzyme-linked immunosorbent
assay.
RESULTS — Among women, adiponectin signiﬁcantly increased after consuming red wine
(29.8%, P  0.05) and increased among men after ethanol solution (17.4%, P  0.05) and
consuming beer (16.1%, P  0.05). De-alcoholized beverages had no substantial effect on
adiponectin concentrations.
CONCLUSIONS — Moderate amounts of ethanol-containing beverages increased adi-
ponectin concentrations, but sex-speciﬁc effects might depend on type of beverage consumed.
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M
oderate alcohol intake is associ-
ated with lower risk for type 2 di-
abetes and fatal and nonfatal
cardiovascular disease (CVD) (1,2). It has
been suggested that alcohol in moderate
doses—in addition to favorable changes
of blood lipids, the hemostatic proﬁle,
and insulin resistance—exhibits anti-
inﬂammatory mechanisms, thus po-
tentially modulating atherosclerosis
development (3). Adiponectin might
represent an important link between in-
sulin resistance, type 2 diabetes, and ath-
erosclerosis. Adiponectin improves
insulin sensitivity and has several anti-
inﬂammatory properties (4), and high
concentrations of adiponectin were asso-
ciated with lower risk of type 2 diabetes
(5,6) and future cardiovascular events
(7). Moderate alcohol consumption is as-
sociated with increased adiponectin con-
centrations in healthy individuals, in
obesemales,andinwomenwithimpaired
glucose tolerance and type 2 diabetes (8–
11). Recently, adiponectin was proposed
to be the most important mediator be-
tween moderate alcohol consumption
and lower incidence of type 2 diabetes
among middle-aged women (12). How-
ever, neither of these studies assessed po-
tential varying effects of different types of
alcoholic beverages in a randomized
setting in men and women; thus, they
mightbepronetoselectionbiasbecause
of personal preferences of study partic-
ipants. Moreover, there is still contro-
versial debate about potential favorable
effects of nonalcoholic ingredients such
as polyphenols.
We investigated the effect of short-
term moderate consumption of either
low-concentrated ethanol solution, red
wine,andbeerwithorwithoutalcoholon
adiponectin in a randomized controlled
crossover intervention trial.
RESEARCH DESIGN AND
METHODS— A total of 72 nonsmok-
ing healthy Caucasian men and women of
German nationality, aged 22–56 years,
wererecruited.Theyweremoderatealcohol
consumers and had a family history free of
alcoholdependencies.Liverdiseasewasex-
cluded measuring liver enzymes. All partic-
ipants gave written informed consent to all
procedures.Thestudywasapprovedbythe
local ethics committee.
After a washout period of at least 2
weeks, participants were randomly allo-
cated, stratiﬁed by age and sex, to the fol-
lowing interventions over 3 weeks: beer
(5.6%), red wine (12.5%), or ethanol
(concentration12.5%),equivalentto30g
ethanol/day for men and 20 g/day for
women or the same amount of de-
alcoholized beer or de-alcoholized red
wine (same brand) or pure water (control
group). After the second washout period
of3weeks,afurtherinterventionwiththe
corresponding beverage followed (beer/
de-alcoholized beer, wine/de-alcoholized
wine, ethanol/water, and vice versa). The
rationale for this study design was avoid-
ance of selection bias caused by prefer-
ences in drinking behavior. All
participants were asked not to change
their dietary habits and habitual physical
activity during the study period.
A baseline history of alcohol con-
sumption,dietaryhabits,medicalhistory,
and sociodemographic parameters was
obtained by standardized interview. At
each visit, symptoms of concurrent in-
ﬂammatory processes/infections includ-
ing fever, cough, or antibiotic therapy
werecarefullyassessedand,ifpresent,the
participant or the respective intervention
period was excluded from analyses. Fast-
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
From the Department of Internal Medicine II, Cardiology, University of Ulm, Ulm, Germany.
Corresponding author: Armin Imhof, armin.imhof@uni-ulm.de.
Received 14 October 2008 and accepted 20 February 2009.
Publishedaheadofprintathttp://care.diabetesjournals.orgon24February2009.DOI:10.2337/dc08-1723.
Clinical trial reg. no. NCT00764426, clinicaltrials.gov.
© 2009 by the American Diabetes Association. Readers may use this article as long as the work is properly
cited, the use is educational and not for proﬁt, and the work is not altered. See http://creativecommons.
org/licenses/by-nc-nd/3.0/ for details.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby
marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Cardiovascular and Metabolic Risk
BRIEF REPORT
DIABETES CARE, VOLUME 32, NUMBER 6, JUNE 2009 1101ing blood was collected from the antecu-
bital vein in a sitting position with
minimal suction and short-term occlu-
sion.Plasmaandserumwasstoredwithin
90 min at 80°C until analysis. Labora-
tory analyses were blinded. Plasma adi-
ponectin concentrations were measured
beforeandafterinterventionbysandwich
enzyme-linked immunosorbent assay
(ELISA) (Quantikine; R&D Systems,
Wiesbaden, Germany).
Statistical analysis
Each intervention group contained 12
males and 12 females undergoing two in-
terventionsinrandomsequence.Datasets
of 16 intervention periods were removed
before analyses because of concurrent in-
fections or dropout, leaving 128 datasets
for analyses. Numbers of excluded data-
sets were similar in all groups and did not
substantially differ between males and fe-
males. ANOVA with mixed linear models
was used to assess the effect of interven-
tions on adiponectin (PROC MIXED in
SAS; SAS Institute, Cary, NC). All tests
performed were two-sided, and a P value
0.05 was considered statistically signif-
icant using SAS software, release 8.2 (SAS
Institute).
RESULTS— Compliance was excel-
lentaccordingtoself-reportandcounting
of empty bottles returned. One partici-
pantwasexcludedbecauseofprotocolvi-
olation. Baseline characteristics including
age, BMI, and liver enzymes did not differ
within sexes and between intervention
groups. Adiponectin concentrations were
substantially higher among females
(means 7.6–8.8 g/ml) than males
(means 4.8–6.3 g/ml) but also did not
differ between the intervention groups
within each sex. Among females, adi-
ponectin signiﬁcantly increased after in-
tervention with red wine (29.8%, P 
0.05) and increased among men after
ethanol solution (17.4%, P  0.05) and
beer consumption (16.1%, P  0.04).
De-alcoholized beverages had no sub-
stantial effect on adiponectin concen-
trations (Fig. 1).
CONCLUSIONS— In this open ran-
domizedcrossoverinterventionstudy,we
found a substantial increase of plasma
concentrations of adiponectin after con-
sumption of moderate doses of alcoholic
beverages for 3 weeks. Among women,
this effect was statistically signiﬁcant after
intake of red wine and among men after
intake of beer and ethanol solution.
This is the ﬁrst study assessing effects
of different alcohol-containing and corre-
sponding de-alcoholized beverages in a
randomized study in both sexes. We con-
ﬁrmandextendﬁndingsfromotherstud-
ies. Adiponectin exhibits a bundle of
various favorable metabolic effects bol-
steringthehypothesisofitspivotalrolein
affectingriskofdiabetesandCVD(4).We
and others observed robust increasing ef-
fects of alcoholic beverages on adiponec-
tin concentrations. This indicates that
adiponectin might partly mediate beneﬁ-
cial effects of these beverages on the re-
spective diseases (8–12). Most strikingly,
effects differ with respect to sex and type of
beverage.However,drinkingpreferencesof
participants might substantially affect our
ﬁndings by incomplete adherence to the
study protocol. Among females, 50% re-
ported to drink preferably wine but only
11% preferred beer in daily life. Among
males, ﬁrst choice was beer for 33% and
winefor22%.Allothersdeniedstrongpref-
erences. Furthermore, experimental and
clinical data suggest that sex hormones af-
fect adiponectin concentrations, and
among healthy males, effects of alcohol on
sex hormones varied by drinking pattern
and between beer and wine, indicating a
potential explanation for our ﬁndings
(13–15).
In summary, our results suggest that
alcohol-containing beverages have robust
increasing effects on adiponectin concen-
trations, but effects might differ between
sexes, depending on type of beverage
consumed.
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